Investing.com - Scisparc reported on Wednesday second quarter earnings that beat analysts' forecasts and revenue that was inline with expectations.
Scisparc announced earnings per share of $0.82 on revenue of $10K. Analysts polled by Investing.com anticipated EPS of $-0.82 on revenue of $10K.
Scisparc shares are down 4.87% from the beginning of the year, still down 89.81% from its 52 week high of $75.60 set on June 11, 2020. They are under-performing the Nasdaq which is up 6.74% from the start of the year.
Scisparc follows other major Healthcare sector earnings this month
Scisparc's report follows an earnings beat by Novo Nordisk ADR on May 5, who reported EPS of $0.8799 on revenue of $5.46B, compared to forecasts EPS of $0.8069 on revenue of $5.21B.
Medtronic had beat expectations on May 27 with fourth quarter EPS of $1.5 on revenue of $8.19B, compared to forecast for EPS of $1.42 on revenue of $8.14B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar